In the wake of debate over regulatory approval standards for medicines, a new survey finds that most physicians favorably view the approaches taken by the Food and Drug Administration, but a key “disconnect” also exists between their perceptions and the reality of the approval process.

Of nearly 700 respondents, 80 percent agreed that the FDA process helps “protect the public from ineffective or dangerous drugs.” And 65 percent reported they were satisfied with the standards used by the FDA to approve medicines, while only 24 percent indicated approval standards are too high, according to a research letter in JAMA Internal Medicine.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy